// App-Quantinova.ai

1711 : The impact of new‐onset diabetes mellitus after transplantation (NODAT) on post‐liver transplant outcomes ‐ the largest non‐registry study

Researchers

Presenter

  • Aloysious D. Aravinthan

Principal Investigators

  • Adam Doyle

  • Zita Galvin

  • Gonzalo Sapisochin

  • Mark Cattral

  • Anand Ghanekar

  • Ian McGilvray

  • Markus Selzner

  • Paul D. Greig

  • David Grant

  • Nazia Selzner

  • Les Lilly

  • Eberhard L. Renner

  • Mamatha Bhat

Medical Centers

  • Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, United Kingdom

  • Division of Nephrology and the Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada

  • Rady College of Medicine, University of Manitoba, Winnipeg, MB, CANADA

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • New-Onset Diabetes after Transplantation

  • End stage renal disease

  • Diabetes

  • Renal disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved